RMD logo

ResMed (RMD) Cash and cash equivalents

annual cash & cash equivalents:

$238.36M+$10.47M(+4.59%)
June 30, 2024

Summary

  • As of today (May 29, 2025), RMD annual cash & cash equivalents is $238.36 million, with the most recent change of +$10.47 million (+4.59%) on June 30, 2024.
  • During the last 3 years, RMD annual cash & cash equivalents has fallen by -$56.92 million (-19.28%).
  • RMD annual cash & cash equivalents is now -73.68% below its all-time high of $905.73 million, reached on June 30, 2014.

Performance

RMD Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRMDbalance sheet metrics

quarterly cash & cash equivalents:

$932.71M+$410.77M(+78.70%)
March 31, 2025

Summary

  • As of today (May 29, 2025), RMD quarterly cash & cash equivalents is $932.71 million, with the most recent change of +$410.77 million (+78.70%) on March 31, 2025.
  • Over the past year, RMD quarterly cash & cash equivalents has increased by +$694.80 million (+292.04%).
  • RMD quarterly cash & cash equivalents is now -7.90% below its all-time high of $1.01 billion, reached on March 31, 2013.

Performance

RMD quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRMDbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

RMD Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.6%+292.0%
3 y3 years-19.3%+362.3%
5 y5 years+62.0%+164.3%

RMD Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-19.3%+4.6%at high+362.3%
5 y5-year-48.5%+62.0%at high+379.6%
alltimeall time-73.7%>+9999.0%-7.9%>+9999.0%

RMD Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$932.71M(+78.7%)
Dec 2024
-
$521.94M(+22.4%)
Sep 2024
-
$426.36M(+78.9%)
Jun 2024
$238.36M(+4.6%)
$238.36M(+0.2%)
Mar 2024
-
$237.91M(+13.2%)
Dec 2023
-
$210.25M(+0.5%)
Sep 2023
-
$209.10M(-8.2%)
Jun 2023
$227.89M(-16.7%)
$227.89M(-0.0%)
Mar 2023
-
$227.89M(-10.0%)
Dec 2022
-
$253.20M(+22.2%)
Sep 2022
-
$207.16M(-24.3%)
Jun 2022
$273.71M(-7.3%)
$273.71M(+35.7%)
Mar 2022
-
$201.77M(+3.8%)
Dec 2021
-
$194.48M(-29.6%)
Sep 2021
-
$276.15M(-6.5%)
Jun 2021
$295.28M(-36.2%)
$295.28M(+28.0%)
Mar 2021
-
$230.63M(-9.9%)
Dec 2020
-
$255.87M(-39.3%)
Sep 2020
-
$421.41M(-9.0%)
Jun 2020
$463.16M(+214.8%)
$463.16M(+31.3%)
Mar 2020
-
$352.86M(+72.9%)
Dec 2019
-
$204.09M(+18.6%)
Sep 2019
-
$172.15M(+17.0%)
Jun 2019
$147.13M(-22.0%)
$147.13M(+0.4%)
Mar 2019
-
$146.51M(-2.0%)
Dec 2018
-
$149.47M(-35.1%)
Sep 2018
-
$230.19M(+22.0%)
Jun 2018
$188.70M(-77.0%)
$188.70M(-73.2%)
Mar 2018
-
$704.28M(-18.0%)
Dec 2017
-
$858.90M(+5.9%)
Sep 2017
-
$811.10M(-1.3%)
Jun 2017
$821.93M(+12.4%)
$821.93M(-0.6%)
Mar 2017
-
$827.31M(+5.0%)
Dec 2016
-
$788.15M(+0.8%)
Sep 2016
-
$781.66M(+6.9%)
Jun 2016
$731.43M(+2.0%)
$731.43M(+1.8%)
Mar 2016
-
$718.50M(+9.1%)
Dec 2015
-
$658.80M(-19.9%)
Sep 2015
-
$822.05M(+14.6%)
Jun 2015
$717.25M(-20.8%)
$717.25M(-17.2%)
Mar 2015
-
$866.33M(-1.6%)
Dec 2014
-
$880.70M(-0.1%)
Sep 2014
-
$881.69M(-2.7%)
Jun 2014
$905.73M(+3.4%)
$905.73M(-3.5%)
Mar 2014
-
$938.56M(-3.5%)
Dec 2013
-
$972.67M(-0.4%)
Sep 2013
-
$976.57M(+11.5%)
Jun 2013
$876.05M(+8.2%)
$876.05M(-13.5%)
Mar 2013
-
$1.01B(+5.7%)
Dec 2012
-
$958.28M(+7.6%)
Sep 2012
-
$890.63M(+10.0%)
Jun 2012
$809.54M(+10.1%)
$809.54M(+4.3%)
Mar 2012
-
$776.07M(+7.3%)
Dec 2011
-
$723.23M(+18.6%)
Sep 2011
-
$610.06M(-17.0%)
Jun 2011
$735.27M(+50.4%)
$735.27M(+9.5%)
Mar 2011
-
$671.70M(+9.0%)
Dec 2010
-
$616.20M(+14.1%)
Sep 2010
-
$540.00M(+10.5%)
Jun 2010
$488.78M
$488.78M(-6.2%)
DateAnnualQuarterly
Mar 2010
-
$520.94M(+15.4%)
Dec 2009
-
$451.43M(-5.5%)
Sep 2009
-
$477.82M(+15.0%)
Jun 2009
$415.65M(+29.5%)
$415.65M(+27.1%)
Mar 2009
-
$327.07M(+2.1%)
Dec 2008
-
$320.49M(+6.1%)
Sep 2008
-
$302.07M(-5.9%)
Jun 2008
$321.08M(+24.5%)
$321.08M(+4.4%)
Mar 2008
-
$307.49M(+10.4%)
Dec 2007
-
$278.50M(+10.8%)
Sep 2007
-
$251.31M(-2.5%)
Jun 2007
$257.79M(+17.4%)
$257.79M(+7.4%)
Mar 2007
-
$240.11M(+3.2%)
Dec 2006
-
$232.67M(+15.7%)
Sep 2006
-
$201.16M(-8.4%)
Jun 2006
$219.54M(+54.4%)
$219.54M(+32.1%)
Mar 2006
-
$166.16M(+18.4%)
Dec 2005
-
$140.28M(+8.1%)
Sep 2005
-
$129.73M(-8.8%)
Jun 2005
$142.19M(+10.3%)
$142.19M(+4.0%)
Mar 2005
-
$136.70M(-4.5%)
Dec 2004
-
$143.07M(+1.0%)
Sep 2004
-
$141.62M(+9.9%)
Jun 2004
$128.91M(+12.6%)
$128.91M(+12.5%)
Mar 2004
-
$114.57M(+6.6%)
Dec 2003
-
$107.46M(+2.7%)
Sep 2003
-
$104.68M(-8.6%)
Jun 2003
$114.49M(+57.1%)
$114.49M(+22.2%)
Mar 2003
-
$93.72M(+13.6%)
Dec 2002
-
$82.47M(+12.1%)
Sep 2002
-
$73.57M(+1.0%)
Jun 2002
$72.86M(+81.5%)
$72.86M(+29.6%)
Mar 2002
-
$56.23M(-12.2%)
Dec 2001
-
$64.05M(+6.0%)
Sep 2001
-
$60.44M(+50.6%)
Jun 2001
$40.14M(+119.9%)
$40.14M(+63.4%)
Mar 2001
-
$24.57M(+45.8%)
Dec 2000
-
$16.86M(+23.8%)
Sep 2000
-
$13.62M(-25.4%)
Jun 2000
$18.25M(+64.4%)
$18.25M(+11.6%)
Mar 2000
-
$16.36M(+42.2%)
Dec 1999
-
$11.50M(+6.5%)
Sep 1999
-
$10.80M(-2.7%)
Jun 1999
$11.10M(-28.4%)
$11.10M(+2.8%)
Mar 1999
-
$10.80M(-20.6%)
Dec 1998
-
$13.60M(-17.6%)
Sep 1998
-
$16.50M(+6.5%)
Jun 1998
$15.50M(+70.3%)
$15.50M(+31.4%)
Mar 1998
-
$11.80M(+55.3%)
Dec 1997
-
$7.60M(-43.3%)
Sep 1997
-
$13.40M(+47.3%)
Jun 1997
$9.10M(+65.5%)
$9.10M(+5.8%)
Mar 1997
-
$8.60M(0.0%)
Dec 1996
-
$8.60M(+32.3%)
Sep 1996
-
$6.50M(+18.2%)
Jun 1996
$5.50M(+66.7%)
$5.50M(+37.5%)
Mar 1996
-
$4.00M(+21.2%)
Jun 1995
$3.30M(-10.8%)
$3.30M(-10.8%)
Jun 1994
$3.70M(+117.6%)
$3.70M(+117.6%)
Jun 1993
$1.70M
$1.70M

FAQ

  • What is ResMed annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for ResMed?
  • What is ResMed annual cash & cash equivalents year-on-year change?
  • What is ResMed quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for ResMed?
  • What is ResMed quarterly cash & cash equivalents year-on-year change?

What is ResMed annual cash & cash equivalents?

The current annual cash & cash equivalents of RMD is $238.36M

What is the all time high annual cash & cash equivalents for ResMed?

ResMed all-time high annual cash & cash equivalents is $905.73M

What is ResMed annual cash & cash equivalents year-on-year change?

Over the past year, RMD annual cash & cash equivalents has changed by +$10.47M (+4.59%)

What is ResMed quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of RMD is $932.71M

What is the all time high quarterly cash & cash equivalents for ResMed?

ResMed all-time high quarterly cash & cash equivalents is $1.01B

What is ResMed quarterly cash & cash equivalents year-on-year change?

Over the past year, RMD quarterly cash & cash equivalents has changed by +$694.80M (+292.04%)
On this page